DrugDashboards

Abiraterone

Abiraterone Acetate · ABIRATERONE ACETATE 500 mg/1 · Tablet · Oral · BluePoint Laboratories

NDC 68001-0673-06 · 60 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

19 companies supply this market — deep enough that no single failure threatens the supply. The price has fallen 49% in a year, to $2.77 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$2.77per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$22.11per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$10.29per TABweighted avg manufacturer price $5.8792 · Aug 1, 2026372% of what pharmacies pay — higher than 95% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$5.00$10.00Oct 2025Sep 2026$2.77
11 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$83.03
#90 count
$249.08

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for abiraterone acetate (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $1,826.30 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA210686
TE code
AB
Approval date
Jul 10, 2019
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Abiraterone Acetate (Tablet)

LabelerStrengthFirst seenLast seen
Dr. Reddys Laboratories IncABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 3, 2026
Apotex Corp.ABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
AvPAKABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesABIRATERONE ACETATE 500 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddys Laboratories IncABIRATERONE ACETATE 500 mg/1Jul 15, 2026Sep 2, 2026
Florida Pharmaceutical Products, LLC.ABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAABIRATERONE ACETATE 500 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.ABIRATERONE ACETATE 125 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.ABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Janssen Biotech, Inc.ABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.ABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LlcABIRATERONE ACETATE 500 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LlcABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.ABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Quallent Pharmaceuticals Health LLCABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.ABIRATERONE ACETATE 250 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.ABIRATERONE ACETATE 125 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript, LLCABIRATERONE ACETATE 250 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Abiraterone — NDC 68001-0673-06," retrieved September 3, 2026, https://drugdashboards.com/drug/68001067306.

Free to cite with attribution — see how the data is put together.